Do You Have Heart Failure?

The University of Chicago and Dr. Beshai are conducting a study that looks at the effect of two different follow-up methods for people who are scheduled to receive an implantable cardioverter defibrillator (ICD) or Cardiac Resynchronization Therapy (CRT) device. Patients are assigned randomly (like the flip of a coin) to one of two groups in this study:

If you are assigned to Group 1, you will come into your doctor’s office for regularly scheduled visits (in-office method).
If you are assigned to Group 2, you will be managed from home (remotely) by having your device send information to a home monitor that plugs into a telephone jack. In this method, your doctor or nurse can look at the information about your device without you needing to go to your doctor’s office.

The immediate benefit to you may be the result in improved management of your device and conditions, which could result in fewer visits to the clinic. However, you may not benefit from participating in this study. This study may have a long-term benefit for you and other subjects by determining the optimal way to follow and manage ICD/CRT subjects. You may be in this study for 15 months.

Participation Details

Initial selection criteria include:

• Must be at least 18 years of age
• Must not have a previous ICD, CRT-D, IPG or CRT-P
• Must be available for clinic visits for the duration of the study
• Must meet medical study criteria as evaluated by Dr. Beshai

Study Director: Dr. John Beshai
Department: Cardiology

For more information contact:
Melody Huntley at 773-834-7157

IRB: #15141A